Diabetologia. 2009 Jan;52(1):17-30. Epub 2008 Oct 22.

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for the Study of Diabetes.

Source

Diabetes Center, Massachusetts General Hospital, Boston, MA 02114, USA. dnathan@partners.org

Abstract

The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The authors continue to endorse the principles used to develop the algorithm and its major features. We are sensitive to the risks of changing the algorithm cavalierly or too frequently, without compelling new information. An update to the consensus algorithm published in January 2008 specifically addressed safety issues surrounding the thiazolidinediones. In this revision, we focus on the new classes of medications that now have more clinical data and experience.

Comment in

PMID:: 18941734; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Hypoglycemic Agents

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. [Diabetes Care. 2009]
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, American Diabetes Association, European Association for Study of Diabetes. Diabetes Care. 2009 Jan; 32(1):193-203. Epub 2008 Oct 22.
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. [Diabetes Care. 2008]
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Diabetes Care. 2008 Jan; 31(1):173-5.
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. [Diabetologia. 2006]
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B, Professional Practice Committee, American Diabetes Association, European Association for the Study of Diabetes. Diabetologia. 2006 Aug; 49(8):1711-21.
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. [Diabetes Care. 2007]
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Mannucci E, Monami M, Pala L, Cocca C, Cresci B, Bardini G, Masotti G, Marchionni N, Rotella CM. Diabetes Care. 2007 Jan; 30(1):193-4.
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. [Diabetes Care. 2006]
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Diabetes Care. 2006 Aug; 29(8):1963-72.

See reviews... See all...

Cited by 29 PubMed Central articles

Efficacy of various antidiabetic agents as add-on treatments to metformin in type 2 diabetes mellitus: systematic review and meta-analysis. [ISRN Endocrinol. 2012]
Efficacy of various antidiabetic agents as add-on treatments to metformin in type 2 diabetes mellitus: systematic review and meta-analysis.
Poolsup N, Suksomboon N, Setwiwattanakul W. ISRN Endocrinol. 2012; 2012:798146. Epub 2012 Mar 27.
Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes. [BMC Endocr Disord. 2012]
Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes.
Sinclair AJ, Alexander CM, Davies MJ, Zhao C, Mavros P. BMC Endocr Disord. 2012 Mar 7; 12:1. Epub 2012 Mar 7.
Comparative effectiveness of incident oral antidiabetic drugs on kidney function. [Kidney Int. 2012]
Comparative effectiveness of incident oral antidiabetic drugs on kidney function.
Hung AM, Roumie CL, Greevy RA, Liu X, Grijalva CG, Murff HJ, Ikizler TA, Griffin MR. Kidney Int. 2012 Apr; 81(7):698-706. Epub 2012 Jan 18.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus al...
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetologia. 2009 Jan ;52(1):17-30. Epub 2008 Oct 22 .

PubMed
Prognostic factors for recurrence following negative second-look laparotomy in o...
Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy.
Gynecol Oncol. 1991 Aug ;42(2):137-41.

PubMed
Novel microchip for in situ TEM imaging of living organisms and bio-reactions in...
Novel microchip for in situ TEM imaging of living organisms and bio-reactions in aqueous conditions.
Lab Chip. 2008 Nov ;8(11):1915-21. Epub 2008 Sep 12 .

PubMed
Contrasting expression of keratins in mouse and human embryonic stem cells.
Contrasting expression of keratins in mouse and human embryonic stem cells.
PLoS One. 2008 ;3(10):e3451. Epub 2008 Oct 20 .

PubMed
A ligand peptide motif selected from a cancer patient is a receptor-interacting ...
A ligand peptide motif selected from a cancer patient is a receptor-interacting site within human interleukin-11.
PLoS One. 2008 ;3(10):e3452. Epub 2008 Oct 20 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: